Mitochondria actively generate ATP via oxidative phosphorylation and constantly undergo high levels of oxidative stress. Lysosomal degradation of mitochondria is a key quality control that inhibits the accumulation of mitochondrial damage. Understanding mitochondrial quality control is critical and urgent because its defects have been linked to many neurological disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Our preliminary data led us to hypothesize that a brain-specific, lysosome- associated isoform of Drp1 GTPase, termed lysoDrp1, enhances transport of mitochondria to lysosomes by increasing the proximity between these two organelles. In this proposed investigation, we will test this hypothesis in two specific aims. In the first aim, we will determine how lysoDrp1 delivers mitochondria into lysosomes (1.1), how GTP regulates lysoDrp1 (1.2), and what recruits lysoDrp1 to lysosomes (1.3). In the second aim, we will determine the function of lysoDrp1 in mitochondrial turnover in neurons (2.1), the role of lysoDrp1-meidated quality control for energy metabolism in neurons (2.2), and the impact of lysoDrp1 on the survival of neurons (2.3). To successfully accomplish these aims, we will use innovative approaches including lysoDrp1-specific mouse knockout generated by CRISPR/Cas9, a fluorescent biosensor for the transport of mitochondria to lysosomes and Drp1-knockout cells reconstituted with single, specific Drp1 isoforms. This work will have a significant impact on translating the mechanistic information of mitochondrial quality control into therapeutic interventions for human diseases.

Public Health Relevance

Abnormalities in mitochondrial degradation are associated with many neurodegenerative diseases. This proposal is aimed at determining the mechanism, regulation and function of the novel mitochondrial quality control pathway mediated by lysoDrp1, providing significant insight into human health and diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM123266-01A1S1
Application #
9728377
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Anderson, Vernon
Project Start
2018-05-01
Project End
2022-02-28
Budget Start
2018-05-01
Budget End
2019-02-28
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Riley, Joel S; Quarato, Giovanni; Cloix, Catherine et al. (2018) Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. EMBO J 37:
Yamada, Tatsuya; Murata, Daisuke; Adachi, Yoshihiro et al. (2018) Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease. Cell Metab 28:588-604.e5
Igarashi, Atsushi; Itoh, Kie; Yamada, Tatsuya et al. (2018) Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility. J Biol Chem 293:9292-9300
Itoh, Kie; Adachi, Yoshihiro; Yamada, Tatsuya et al. (2018) A brain-enriched Drp1 isoform associates with lysosomes, late endosomes, and the plasma membrane. J Biol Chem 293:11809-11822